10 Small Stocks with Mighty Gains

Page 9 of 9

1. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Ironwood Pharmaceuticals soared by 23.32 percent on Wednesday to end at $3.86 apiece as investors cheered the new price set by the Health Department for its bowel treatment, which fell in line with its expectations.

In a regulatory filing, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) said that the US Department of Health and Human Services released the maximum fair price (MFP) for Linzess to $136.

“The revised MFP for LINZESS is in line with the expectations of Ironwood Pharmaceuticals, Inc.,” it said. The new price will take effect on January 1, 2027.

Linzess was among the treatments selected in the most recent round of government price setting as part of the Inflation Reduction Act of 2022, in a bid to make healthcare costs more affordable to American senior citizens.

According to the Centers for Medicare and Medicaid Services (CMS), the lower Medicare would help save the government billions of dollars in healthcare costs, at least $12 billion if it started in 2024.

In recent news, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) said it expanded its net income by 1,013 percent in the third quarter of the year to $40.08 million from $3.6 million in the same period last year.

Revenues jumped by 33.27 percent to $122.06 million from $91.59 million year-on-year, thanks to $119.6 million of US revenues from Lizness.

While we acknowledge the potential of IRWD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IRWD and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.

Page 9 of 9